CBDS · Cannabis Sativa, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $192.9K | - | $190.6K | $192.5K | $184.5K | - | $189.1K | $234.4K | $225.1K | - |
| Cost of Revenue | $66.7K | - | $68.6K | $71.0K | $67.5K | - | $70.2K | $84.1K | $99.0K | - |
| Gross Profit | $126.2K | - | $121.9K | $121.5K | $117.0K | - | $118.9K | $150.3K | $126.1K | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $123.7K | - | $120.2K | $186.9K | $105.2K | - | $102.7K | $153.3K | $124.9K | - |
| Total Operating Expenses | $283.4K | - | $269.1K | $304.9K | $218.6K | - | $300.7K | $348.2K | $300.9K | - |
| D&A | $301 | - | $301 | $302 | $301 | - | $301 | $302 | $2.4K | - |
| Operating Income | ($157.2K) | - | ($147.2K) | ($183.4K) | ($101.6K) | - | ($181.8K) | ($197.9K) | ($174.8K) | - |
| Interest Expense | $13.6K | - | $57.9K | $11.9K | $9.7K | - | $7.4K | $9.2K | $8.3K | - |
| Income Tax | $0 | - | $0 | $0 | $0 | - | $0 | $0 | $0 | - |
| Net Income | ($200.5K) | - | ($178.4K) | ($7.30M) | ($107.4K) | - | ($241.1K) | ($390.8K) | ($222.6K) | - |
| EPS - Basic | - | - | - | - | - | - | - | - | - | - |
| EPS - Diluted | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19.5K | $29.6K | $30.0K | $50.8K | $34.9K | $34.9K | $41.4K | $61.2K | $59.0K | $83.8K |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $905.1K | $944.9K | $780.0K | $792.7K | $360.5K | $352.0K | $59.4K | $86.7K | $79.8K | $160.0K |
| Total Assets | $2.19M | $2.23M | $2.06M | $2.08M | $1.72M | $1.71M | $1.92M | $1.94M | $1.94M | $2.02M |
| Current Liabilities | $870.2K | $840.1K | $797.2K | $781.6K | $746.9K | $715.7K | $749.9K | $764.7K | $607.5K | $485.4K |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $2.37M | $2.26M | $2.13M | $2.07M | $1.95M | $1.84M | $1.79M | $1.65M | $1.40M | $1.26M |
| Stockholders' Equity | ($2.02M) | ($1.87M) | ($1.78M) | ($1.72M) | ($1.54M) | ($1.44M) | ($1.19M) | ($1.03M) | ($802.8K) | ($602.5K) |
| Retained Earnings | ($84.59M) | ($84.39M) | ($84.31M) | ($84.13M) | ($83.92M) | ($83.82M) | ($82.90M) | ($82.66M) | ($82.28M) | ($82.08M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($13.4K) | - | - | - | $4.1K | - | - | - | ($24.7K) | - |
| Investing Cash Flow | ($600) | - | - | - | $0 | - | - | - | $0 | - |
| Financing Cash Flow | $4.0K | - | - | - | $450 | - | - | - | $0 | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 65.4% | - | 64.0% | 63.1% | 63.4% | - | 62.9% | 64.1% | 56.0% | - |
| Operating margin | -81.5% | - | -77.2% | -95.3% | -55.1% | - | -96.2% | -84.5% | -77.6% | - |
| EBITDA margin | -81.3% | - | -77.1% | -95.1% | -54.9% | - | -96.0% | -84.3% | -76.6% | - |
| Net margin | -103.9% | - | -93.6% | -3790.5% | -58.2% | - | -127.5% | -166.7% | -98.9% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 64.1% | - | 63.1% | 97.1% | 57.0% | - | 54.3% | 65.4% | 55.5% | - |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -9.2% | - | -8.7% | -351.5% | -6.2% | - | -12.6% | -20.1% | -11.5% | - |
| Return on equity | 9.9% | - | 10.0% | 424.4% | 7.0% | - | 20.2% | 38.1% | 27.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.04 | 1.12 | 0.98 | 1.01 | 0.48 | 0.49 | 0.08 | 0.11 | 0.13 | 0.33 |
| Quick ratio | 1.04 | 1.12 | 0.98 | 1.01 | 0.48 | 0.49 | 0.08 | 0.11 | 0.13 | 0.33 |
| Cash ratio | 0.02 | 0.04 | 0.04 | 0.07 | 0.05 | 0.05 | 0.06 | 0.08 | 0.10 | 0.17 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | -11.6x | - | -2.5x | -15.4x | -10.5x | - | -24.7x | -21.4x | -21.2x | - |
| Equity multiplier | -1.08 | -1.19 | -1.16 | -1.21 | -1.11 | -1.19 | -1.61 | -1.89 | -2.41 | -3.35 |
| Liabilities / Assets | 1.08 | 1.01 | 1.03 | 1.00 | 1.14 | 1.08 | 0.93 | 0.85 | 0.72 | 0.63 |
| Efficiency | ||||||||||
| Asset turnover | 0.09 | - | 0.09 | 0.09 | 0.11 | - | 0.10 | 0.12 | 0.12 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 4.6% | - | 0.8% | -17.9% | -18.1% | - | -30.3% | -27.5% | -34.8% | - |
| Revenue CAGR (3y) | -17.6% | - | -20.8% | -25.0% | -24.2% | - | -25.8% | -22.7% | -26.1% | - |
| Revenue CAGR (5y) | -19.1% | - | -16.2% | -23.2% | -17.9% | - | -16.1% | 9.2% | 17.6% | - |
| Gross profit growth (YoY) | 7.9% | - | 2.6% | -19.2% | -7.3% | - | -29.6% | -25.8% | -47.4% | - |
| Operating income growth (YoY) | -54.7% | - | 19.1% | 7.3% | 41.9% | - | 17.9% | 35.1% | -55.6% | - |
| Net income growth (YoY) | -86.7% | - | 26.0% | -1766.9% | 51.8% | - | -178.3% | -23.5% | 55.5% | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -30.9% | -29.9% | -49.7% | -67.5% | -92.2% | -138.8% | -237.8% | -220.2% | -597.0% | - |
Peer comparison
Same SIC group: Services-Personal Services
Comparing Cannabis Sativa against the 5 most active filers in the same SIC group.